NCT07850752: A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy
- State
- Under way
- Phase
- Phase 3
- People
- 340 planned
- Started
- 11 Nov 2026
- Primary completion
- 17 Sep 2028
- Arms
- zigakibart + atrasentan
- Results
- None posted
- 30 Sep 2026: Trial registered
- 11 Nov 2026: Trial started